May 7, 2020 / 1:05 PM / a month ago

BRIEF-Enlivex Announces Initiation Of Multi-Center Phase 2 Investigator-Initiated Clinical Trial Of Allocetra In COVID-19 Patients

May 7 (Reuters) - Enlivex Therapeutics Ltd:

* ENLIVEX ANNOUNCES INITIATION OF MULTI-CENTER PHASE II INVESTIGATOR-INITIATED CLINICAL TRIAL OF ALLOCETRA IN COVID-19 PATIENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below